Refine Results
- view as grid
- view as list
Why The California Recall Is Not a Harbinger of What Is to Come on COVID As a Campaign Issue
In this Axios column, Drew Altman examines the lessons for COVID-19 as a political issue from Governor Gavin Newsom’s resounding win in California’s recall election.
Perspective Read More
Vaccines Are Free. Covid Care Is Not. Who Should Pay?
In this commentary for Barron’s, Cynthia Cox explores the impact to the American public as the U.S. health insurance system adjusts to the COVID-19 pandemic. She uses the experience of the past year and a half to raise questions about broader issues of fairness in the distribution of health care costs in the country.
Perspective Read More
Parents Report More Negative Pandemic Effects on Kids Who Attend School Virtually vs. In-Person
In his latest Axios column, Drew Altman shows that parents feel that children have fared better during COVID attending school in-person than virtually in terms of academic performance and their mental health and wellbeing.
Perspective Read More
How Full FDA Approval Could Spur Vaccination
In this Axios column, Drew Altman says full FDA approval of COVID-19 vaccines can provide a big boost to vaccination efforts if treated as an opportunity for updated messaging from government officials at all levels and public health experts and new actions from employers.
Perspective Read More
The Health System Appears To Be Selling LGBT+ People Short
With much focus on equity in the nation’s health care system during the pandemic, Drew Altman’s Axios column brings attention to warning signs about health care provided to LGBT+ individuals.
Perspective Read More
The Sleeper Health Cost Policy
In this Axios column, Drew Altman unpacks President Biden’s recent executive order on promoting competition, exploring its significance for new efforts to control health costs by addressing consolidation in the health care industry.
Perspective Read More
Why Drug Price Negotiation Has Staying Power
In this Axios column, Drew Altman looks beyond Medicare to what’s at stake for employers and workers in the debate about the government negotiating drug prices.
Perspective Read More
Expanding Medicare to Adults at Age 60 Years—Medicare-for-More?
In this column for the JAMA Health Forum, Larry Levitt examines the implications of lowering Medicare’s age of eligibility, which is emerging as a potential pathway toward Medicare-for-all or a public option among single-payer advocates. He explores the implications for costs, industry, people and broader reform efforts.
Perspective Read More
Persistent Vaccine Myths
With news that the country has now vaccinated half of its population with at least one dose, This Drew Altman Axios column highlights the persistent COVID-19 vaccine myths that are believed by a substantial portion of the unvaccinated population and discusses the options to address vaccine misinformation.
Perspective Read More
We aren’t getting a national vaccine ‘passport.’ So let’s use the next best thing: CDC vaccination cards.
In this op-ed for The Washington Post, Drew Altman suggests a way out of the heated debate about a COVID-19 vaccination passport to help provide clarity about who is vaccinated and who still ought to wear masks in public spaces or the workplace by using something that already exists– CDC vaccination cards.
Perspective Read More